About My Gene Counsel
My Gene Counsel is a company based in New Haven (United States) founded in 2014. My Gene Counsel has raised $1.36 million across 3 funding rounds. My Gene Counsel offers products and services including Living Lab Reports and One-Stop Program. My Gene Counsel operates in a competitive market with competitors including Omniome, Novogene Corporation, Tessera Therapeutics, Phase Genomics and HitGen, among others.
- Headquarter New Haven, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.36 M (USD)
in 3 rounds
-
Latest Funding Round
$661.57 K (USD), Seed
May 02, 2018
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of My Gene Counsel
My Gene Counsel offers a comprehensive portfolio of products and services, including Living Lab Reports and One-Stop Program.
Provides updated genetic information for precision medicine users.
Offers comprehensive genetic counseling resources for stakeholders.
Funding Insights of My Gene Counsel
My Gene Counsel has successfully raised a total of $1.36M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $661.57 thousand completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by My Gene Counsel
Investment portfolio details for My Gene Counsel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - My Gene Counsel
Detailed financials for My Gene Counsel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
My Gene Counsel Comparisons
Peer comparison for My Gene Counsel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of My Gene Counsel
My Gene Counsel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Tessera Therapeutics, Phase Genomics and HitGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Next-generation gene sequencing and multi-omics technologies are provided.
|
Detailed competitors of My Gene Counsel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on My Gene Counsel
Complete news archive for My Gene Counsel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about My Gene Counsel
My Gene Counsel was founded in 2014 and raised its 1st funding round 2 years after it was founded.
My Gene Counsel is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
My Gene Counsel is a funded company, having raised a total of $1.36M across 3 funding rounds to date.
Founded in 2014 and based in New Haven, United States, My Gene Counsel operates in the genetic health sector. Genetic test results are matched with accessible information for users. Real-time updates on genetic data are delivered through its platform. Services focus on counseling to support informed decision-making in healthcare. The domain mygenecounsel.com is utilized for operations.
My Gene Counsel's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.
My Gene Counsel offers Living Lab Reports and One-Stop Program.